Among the most popular portfolio startups of the fund, we may highlight ProFactor Pharma. Among the most popular fund investment industries, there are Medical, Health Care.
The standard case for the fund is to invest in rounds with 5 partakers. Despite the Coagulare Biomedica, startups are often financed by Scottish Enterprise, Kelvin Capital, Ingenza. The meaningful sponsors for the fund in investment in the same round are Scottish Enterprise, Lancaster Capital, Kelvin Capital. In the next rounds fund is usually obtained by Kelvin Capital, Ingenza, Scottish Investment Bank.
Deals in the range of 100 thousands - 1 million dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2015.
Related Funds
| Fund Name | Location |
| AI Alliance | Gauteng, NA - South Africa, South Africa |
| Axis Capital | India, Maharashtra, Mumbai |
| Chip One Stop | Japan, Kanagawa Prefecture, Yokohama |
| CMG-SDIC Capital Management | Beijing, Beijing, China |
| CPC & Partners | Canada, Ontario, Toronto |
| Edelweiss Alternative Asset Advisors | - |
| Hongfan Capital | - |
| Inventures Group | California, Palo Alto, United States |
| Ironfire Ventures | China, Hong Kong, Hong Kong Island |
| Medtech Syndicate Nominee | - |
| National Bank of Canada | NAventures | Canada, Montréal, Quebec |
| NTT Venture Capital | California, Menlo Park, United States |
| Osprey Ventures | California, Palo Alto, United States |
| Pequot Capital | Connecticut, United States, Westport |
| Shinsegae I&C | - |
| SPF Investment Management | New York, New York, United States |
| Tianshiyun Jiaoyu | Beijing, China, Haidian |
| Wonderful Sky Financial Group | - |
| Zebra Ventures | Illinois, Lincolnshire, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 